Nordea Investment Management’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
Nordea Investment Management's EVH Position: Q1 2026 in Review
Nordea Investment Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 120,455 shares — an estimated $481K sold.
Nordea Investment Management first reported a position in EVH in Q1 2021 and held it in 15 quarters. The position peaked at $3.98M in Q3 2021. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- Nordea Investment Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
- Nordea Investment Management sold 120,455 Evolent Health shares in Q1 2026, an estimated $481K.
- Nordea Investment Management first reported a position in Evolent Health in Q1 2021 and held it in 15 quarters.
- Nordea Investment Management's Evolent Health position peaked at $3.98M in Q3 2021.
- 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.